William Blair analyst Jonathan Ho has maintained their bullish stance on CLBT stock, giving a Buy rating yesterday.
TipRanks Cyber Monday Sale
- Claim 60% off TipRanks Premium for data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Jonathan Ho has given his Buy rating due to a combination of factors that highlight Cellebrite DI’s strategic growth potential and financial prospects. The recent acquisition of Corellium is a significant driver, as it enhances Cellebrite’s digital investigative capabilities by allowing virtual interaction with mobile operating systems. This acquisition not only strengthens their offerings in digital investigations but also expands their reach into the private sector by supporting developers and security teams.
Furthermore, Ho identifies several catalysts for growth leading up to 2026. These include the continued upgrade cycle of Inseyets, strong growth in their Guardian product, anticipated FedRAMP approval, and the introduction of the Guardian Investigate product. Additionally, the potential renewal of a significant U.S. federal contract adds to the positive outlook. Ho’s confidence is further reinforced by the appointment of Tom Hogan as permanent CEO, suggesting a belief in the company’s future prospects. Overall, these elements contribute to an expected EBITDA growth and a potential upside of over 20% in the next year.
In another report released yesterday, Lake Street also maintained a Buy rating on the stock with a $23.00 price target.